SCHEMBL467537

SCHEMBL467537

CCN(CC)C1CCN(c2ccc(-n3nc(N)nc3N)cc2F)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHIT1 Q13231 3/20 0.36
CHIA Q9BZP6 3/20 0.36
GAA P10253 2/20 0.35
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
DPP7 Q9UHL4 1/20 0.35
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ADORA2A P29274 3/20 0.34
ACKR3 P25106 1/20 0.34
MAOB P27338 3/20 0.33
AXL P30530 2/20 0.33
ADORA1 P30542 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
GFER P55789 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28998140 0.94 FPR1 (0.35) CHIT1CHIAGAADPP4DPP8
SCHEMBL28784754 0.92 DRD2 (0.38) GAAHPGDSMN1; SMN2MAPT
SCHEMBL27769791 0.85 ALDH1A1 (0.37) GAAHPGDSMN1; SMN2ADORA2AAXL
SCHEMBL467601 0.81 FLT3 (0.36) GAAAXLALDH1A1LMNAMAPT
SCHEMBL27789423 0.81 HPGD (0.41) GAADPP4DPP8DPP9DPP7
SCHEMBL18009413 0.79 ALDH1A1 (0.46) GAASMN1; SMN2AXLALDH1A1LMNA
SCHEMBL467659 0.79 AXL (0.49) AXLALDH1A1LMNAMAPTMAPK1
SCHEMBL13276198 0.79 ADORA2A (0.40) ADORA2AAXLADORA1ALDH1A1LMNA
SCHEMBL467478 0.79 AXL (0.42) GAAHPGDSMN1; SMN2AXLALDH1A1
SCHEMBL467696 0.79 AXL (0.43) AXLALDH1A1CDK4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116075303-A Method of selecting patients treated with a combination of an AXL inhibitor and an immune checkpoint modulator 卑尔根生物股份公司 2023-05-05 CN disclosed
CN-115916344-A AXL inhibitors for antiviral therapy 卑尔根生物股份公司 2023-04-04 CN disclosed
EP-4138823-A1 METHOD OF SELECTING PATIENTS FOR TREATMENT WITH A COMBINATION OF AN AXL INHIBITOR AND AN IMMUNE CHECKPOINT MODULATOR BerGenBio ASA (NO) 2023-03-01 EP disclosed
EP-2387395-A1 AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER Rigel Pharmaceuticals, Inc. (US) 2011-11-23 EP disclosed
US-8040491-B2 Exposure method, substrate stage, exposure apparatus, and device manufacturing method NIKON CORPORATION (JP) 2011-10-18 US disclosed